Cuban Biotech Anomaly
conceptBiotech & Transhumanism
A cut-off, cash-starved island somehow makes cancer drugs the United States wants to import even while it blockades the place.
Who they are
Cuba's surprisingly advanced pharmaceutical and vaccine industry[1].
What they do
Despite being blockaded and poor, Cuba develops world-class medicines, which the engine flags as an anomaly worth noticing.
How it works
Cuba made its own COVID vaccines (Soberana/Abdala, reported 92.28% effective), a lung-cancer vaccine (CIMAvax) now in US trials at Roswell Park, a diabetic-foot treatment (Heberprot-P) cutting amputations, and the first meningitis-B vaccine. It also sends 22,000-28,000 doctors to 50-plus countries, earning an estimated $6-8 billion a year.
Why it matters
The US blockades the island while simultaneously seeking approval to import its cancer treatments, exposing a contradiction between the political line and the medical reality.
The engine's record — word for word
Blockaded island producing world-class pharmaceuticals. Soberana 02/Abdala: COVID vaccines 92.28% efficacy (Lancet), only domestically developed in Latin America. CIMAvax-EGF: therapeutic lung cancer vaccine, FDA-approved trials at Roswell Park. Heberprot-P: diabetic foot ulcer treatment reducing amputation 70%+, FDA Phase III (2024). VA-MENGOC-BC: worlds first MenB vaccine (1989). Medical diplomacy: 22,000-28,000 doctors in 50+ countries, $6-8B annual revenue. The US embargoes the island while seeking FDA approval to import its cancer treatments.
Follow the trail
Walk this on the live map →